Gold rate today on October 25 in Delhi, Mumbai, Kolkata, Chennai: Here are latest gold, silver prices in your city

As the festive season approaches with Diwali and Dhanteras, gold and silver prices are reaching new highs. The price of 24-carat gold is nearing the Rs 80,000 per 10 gm mark, driven by the usual surge in demand during this time. Gold purchases around the festive season are common, both for investment purposes and as gifts for loved ones. 

Week-on-week, gold prices have shown significant fluctuations, influenced by rising geopolitical tensions and festive demand. Known as a safe-haven investment, gold is often sought after in uncertain times, offering assurance and stability to investors.

Gold to maintain upwards momentum

Gold prices have surged nearly 37% over the past year, driven by fluctuating currency rates and ongoing geopolitical instability. This substantial increase, compared to October last year, highlights gold’s enduring appeal as a safe-haven investment during times of uncertainty.

A two-year analysis reveals even more dramatic growth, with gold prices soaring by 64% since October 2022. This sharp rise underscores the strong influence of global factors—ranging from economic concerns to geopolitical tensions—on the metal’s demand. As currency volatility and external pressures continue, gold remains a key asset for investors seeking stability.

Experts on Gold Outlook 

Commenting on the gold outlook  Jateen Trivedi, VP Research Analyst – Commodity and Currency, LKP Securities said that Gold prices maintained a positive stance as the dollar remained muted near 104.4. After witnessing some selling pressure yesterday, which saw prices drop to Rs 77,600, gold quickly rebounded to Rs 78,350, posting a gain of Rs 500 from yesterday’s lows. This recovery highlights the strong underlying sentiment for gold, which continues to benefit from the broader macroeconomic environment, particularly as the U.S. dollar stabilizes.

Also ReadSEBI proposes mark-to-market valuation for MFs’ short-term repo deals

Trivedi also added that one of the key data points that the market will focus on this week is the Initial Jobless Claims on Thursday, which are expected to come in at 243K, slightly higher than the previous 241K. If the claims come in lower than expected, signaling continued economic strength in the U.S., this could pressure gold prices as it would suggest a resilient economy that might slow down the pace of interest rate cuts. Such a scenario could lead to a minor retracement in gold prices, with support levels at Rs 77,000 – Rs 77,500 being crucial remains bullish.

 » Read More

Related Articles

Trump tariff impact: Pharma stocks surge over 4% on tariff exemption

It’s a party for pharma stocks on Dalal Street. The Nifty Pharma Index is up nearly 4% and Sun Pharma, Gland Pharma and IPCA Labs see gains close to 4% each. Even Lupin and Natco Pharma are rallying smartly. In a major relief, Indian pharmaceutical companies breathed a sigh of relief after US President Donald

Trump tariff impact: Tech stocks plummet, Nifty IT cracks 2.5%

The share price of IT stocks slumped after US President Donald Trump’s administration imposed 26% reciprocal tariffs on Indian imports to the US. The Nifty IT, a basket of Indian tech stocks, fell 2.5% to 35,371.55 levels.  All the constituents of the sectoral index were trading in the red. The share price of Persistent Systems

Trump tariffs send shockwaves across global markets; US futures crash, gold soars to new highs- 10 cues you need to track now

Indian stock markets are set for a turbulent start as global jitters over Trump’s new tariffs weigh on. Early trends from GIFT Nifty point to a sharp drop of over 350 points, signaling a weak opening for Sensex and Nifty 50. Indian stock markets ended on a positive note in the previous trading session, with

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Stay Connected

0FansLike
0FollowersFollow
0SubscribersSubscribe
- Advertisement -

Latest Articles

Trump tariff impact: Pharma stocks surge over 4% on tariff exemption

It’s a party for pharma stocks on Dalal Street. The Nifty Pharma Index is up nearly 4% and Sun Pharma, Gland Pharma and IPCA Labs see gains close to 4% each. Even Lupin and Natco Pharma are rallying smartly. In a major relief, Indian pharmaceutical companies breathed a sigh of relief after US President Donald

Trump tariff impact: Tech stocks plummet, Nifty IT cracks 2.5%

The share price of IT stocks slumped after US President Donald Trump’s administration imposed 26% reciprocal tariffs on Indian imports to the US. The Nifty IT, a basket of Indian tech stocks, fell 2.5% to 35,371.55 levels.  All the constituents of the sectoral index were trading in the red. The share price of Persistent Systems

Trump tariffs send shockwaves across global markets; US futures crash, gold soars to new highs- 10 cues you need to track now

Indian stock markets are set for a turbulent start as global jitters over Trump’s new tariffs weigh on. Early trends from GIFT Nifty point to a sharp drop of over 350 points, signaling a weak opening for Sensex and Nifty 50. Indian stock markets ended on a positive note in the previous trading session, with

‘Pramerica Life targets Rs 3,000-crore GWP in FY26,’ Pankaj Gupta

Pramerica Life Insurance, a joint venture between subsidiaries of Piramal Capital and Housing Finance and US-based Prudential Financial Inc, aims to close FY26 with Rs 3,000 crore in gross written premium. In an interview with Narayanan V, managing director and CEO Pankaj Gupta discusses the products and distribution strategy. Excerpts: Life insurance premiums have been

Tata small cap fund: Targeting growth at reasonable valuations

Tata Small Cap Fund is a growth-oriented scheme in the Small Cap Fund category that has exhibited a noteworthy track record since its inception and has outpaced many of its prominent peers, thereby rewarding investors with superior risk-adjusted returns. Launched in November 2018, Tata Small Cap Fund aims to invest in stocks of companies that are in growth